Document is current
Any future updates will be listed below
-
Authors
Moreel, Lien https://orcid.org/0000-0002-7613-4801
Betrains, Albrecht
Boeckxstaens, Lennert
Pieters, Griet
Wuyts, Els
Weynand, Birgit
Fourneau, Inge
Van Laere, Koen
Demaerel, Philippe
De Langhe, Ellen
Vanderschueren, Steven
Blockmans, Daniel
- License Information
-
More Information
Article History
Received: 16 January 2025
Accepted: 14 February 2025
First Online: 26 February 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the ethical committee of UZ Leuven (S69201).
: Informed consent was waived because of the retrospective nature of the study and the analysis used pseudonymized clinical data.
: LM has received research support from Roche and travel support from Abbvie; AB: none; LB: none; GP: none; EW: none; BW: none, IF: none KVL: none; PD: none; EDL has received consulting fees from Boehringer Ingelheim, GSK, Astra Zeneca and Otsuka, a speaking fee from Actelion and Novartis and travel support from Astra Zeneca and was a board member for AC Immune; SVDS: none; DB has received research support from Roche and consulting fees from Roche, GSK and Eli Lily and was a board member of Roche and GSK.
